Humana CEO, Bartholomew "Bart" Gold, today issued a tearful apology to shareholders after the company’s quarterly profit, though substantial, failed to meet analysts' most aggressive expectations. Gold expressed profound regret that the health insurance giant only maintained its adjusted profit outlook of $9 per share, lamenting the "untapped potential for wealth extraction" from its ailing customers.
"We understand that our shareholders expect us to wring every last cent out of human fragility, and frankly, we fell short," Gold said, wiping away a solitary tear with a wad of unapproved medical bills. "While we successfully denied thousands of life-saving procedures, incrementally raised premiums for millions, and made accessing care an Olympic-level bureaucratic sport, there were still too many instances where patients somehow managed to retain a small portion of their personal wealth. This will not stand. We must do better for our investors."
Financial analyst Chantal Dubois of "Predatory Capital Advisors" echoed the sentiment, calling Humana’s performance "a missed opportunity to truly dominate the illness economy, leaving literal billions on the table." Dubois specifically highlighted the company's failure to adequately charge for "the emotional toll of navigating our Byzantine appeals process, the psychic burden of endless hold music, and the sheer audacity of expecting timely medical attention." "Shareholders aren't looking for mere billions," Dubois stated in a memo to investors. "They’re looking for *every* billion. We expect Humana to learn from this quarter’s disappointing restraint and unleash the full force of its actuarial might upon the American populace, turning every cough into pure gold."
To rectify this egregious oversight, Humana announced a new "Patient Profit Optimization" initiative, aiming to "streamline" the process of turning medical necessity into revenue streams. Components include mandatory "wellness fees" for not being sick enough to use services, a "catastrophic health event surcharge" for those whose illnesses cost too much, and a tiered system for customer service where access to a human being directly correlates with annual premium spend. "Our goal is not just to provide care, but to ensure that the journey to financial ruin is as efficient as possible for both parties," Gold explained, now almost beaming.
Humana pledged an aggressive strategy for the coming year, including "innovative new ways to reclassify pre-existing conditions" and "optimizing the denial-to-approval ratio," ensuring that no illness goes un-monetized, and no shareholder suffers the indignity of merely adequate returns. The company is confident that by year-end, any lingering hope for affordable healthcare will be crushed under the weight of maximized shareholder value.
